IBD-Associated Arthritis

Top Story

Anti-tumor Necrosis and Inflammatory Bowel Disease

Healio Rheumatology, June 2017
Edouard Louis, MD, PhD
In the Journals

Biosimilars unlikely to save costs as expected, experts say

May 4, 2017
Despite being heralded as lower-cost alternatives to branded biologics, the approval of biosimilar therapies for chronic diseases is not likely to yield expected cost…
Meeting NewsVideo

VIDEO: Speaker reviews factors that impact response to treatment for Crohn’s disease, ulcerative colitis

March 28, 2017
NEW YORK — At the Interdisciplinary Autoimmune Summit, Steven B. Hanauer, MD, medical director of the Digestive Health Center at Northwestern University, Feinberg…
Curbside Consultation

Biologic Therapies for Inflammatory Bowel Disease

Healio Rheumatology, March 2017
Maria Laura Annunziata, MD, PhD; David T. Rubin, MD
A: Current biologic therapies for inflammatory bowel disease include infliximab and adalimumab, which were approved in North America, Australia and Western Europe…
More Headlines »
CME ABIM MOC

Ace the Case: A 24-Year-Old Female with Chronic Low-Back Stiffness

There is no commercial support for this activity.

This “Ace the Case” study will explore the diagnosis and management of a young adult with back pain. Accurately assess…
More »
Video
Meeting News

VIDEO: Speaker reviews factors that impact response to treatment for Crohn’s disease, ulcerative colitis

March 28, 2017
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

CME

The Role of the Inflammatory Cascade in the Pathogenesis and Treatment of Psoriatic Arthritis: New and Emerging Therapies

This activity is supported by educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.

The workings of the inflammatory cascade are not fully defined, but recent findings have demonstrated roles for novel…
More »